Page 161 - Reuters%20/undefined

Premier Energies halts US solar cell facility plans amid policy uncertainty

Concerns over US stance on clean energy have weighed on shares of Premier, which have lost about 23% since hitting a peak in December, after listing in September

Castrol India reports 12% rise in profit for Dec quarter on steady demand

Quarterly revenue grew 7.1 per cent to 13.54 billion rupees in the October to December quarter due to higher sales of its lubricants for two-wheelers and commercial vehicles

Tata Chemicals Q3 results: Loss at Rs 53 crore, revenue declines 3.8%

Tata Chemicals said it incurred a non-cash writedown on assets aggregating to 700 million rupees with respect to its UK operations

Too early to discuss Zelenskyy's four-way peace talks format: Kremlin

Moscow has long said the fact that Zelenskiy was not re-elected last year when his 5-yr term expired - due to martial law being in force - means he would not have legal authority to sign a peace deal

WHO proposes to cut budget by $400 mn after US exit, defends its work

The budget cut will be addressed at the Feb. 3-11 Geneva meeting, during which member state representatives will discuss the agency's funding and work for the 2026-27 period

S&P upgrades Vedanta Resources' rating on reduced refinancing risk

Vedanta Resources has seen its rating being upgraded in recent months after seeking to lower its debt and improve its capital structure

Russia, Trump push Europe to be more independent, says French Prez Macron

Macron made the comments as he arrived at a gathering of European Union leaders in Brussels to discuss relations with the United States and bolstering Europe's military defences

Trump's anti-DEI policies impact public, private sectors across US

The impacts will be felt among underrepresented groups, along with a shrinking number of people in DEI-related positions in both the public and private sectors, experts said

Gold pares early losses as Trump tariffs drive interest in safe-haven

Gold, often regarded as a safe-haven investment during periods of economic or geopolitical instability, soared to a record peak of $2,817.23 on Friday

Oil prices rise as Trump's tariffs on Mexico, Canada, China stoke fears

Gasoline pump prices in the US are certainly expected to rise with the loss of crude for refineries and the loss of imported products, said Mukesh Sahdev at Rystad Energy

Gland Pharma Q3 result: Net profit rises 7% to Rs 205 cr as expenses drop

Rivals Sun Pharma and Cipla beat third-quarter profit estimates, while Dr Reddy's missed expectations. All three drugmakers saw muted growth in the North American market, including the US

Wall Street joins global stock slide, pares losses with Mexico tariff pause

Automakers, chip stocks fall after Trump announces trade tariffs

RBI's bond holdings to be treated at par with mkt, no swap for longer debt

The government aims to conduct a switch target of 2.50 trillion rupees in the next financial year, but there is no specific amount earmarked for buybacks

RBI may purchase Rs 2 trn of bonds in FY26, says DBS Bank's Vaidya

The Reserve Bank of India last week resumed bond purchase auctions after a gap of more than three years and plans to buy more in the coming weeks

Rupee sinks to lifetime low as Trump tariffs shake global markets

The rupee declined to 87.28 per U.S. dollar before closing at 87.1850, down by nearly 0.7%, its biggest single-day percentage loss since Jan 13

Saudi Arabia, UAE expected venues for Trump-Putin meet: Russian sources

However, senior Russian officials have visited both Saudi Arabia and the UAE in recent weeks, according to the Russian sources, who spoke on condition of anonymity due to the sensitivity of situation

Alembic Pharma Q3 result: Profit dips 23% to Rs 138 cr on weak sales

A significant chunk of revenue for most Indian generic drugmaker comes from the U.S. and fierce competition in the North American market has weighed on domestic firms' margins

Divi's Labs Q3 results: PAT rises 64.5% to Rs 589 cr on strong API demand

Its revenue from operations climbed 25 per cent to Rs 2,319 crore during the quarter, roughly in line with analysts' estimate of Rs 2,343 crore

RBI's forex forward book climbed to near 4-year high on rupee angst

RBI buys or sells dollars in the FX forward market when it does not want its spot intervention to affect domestic liquidity and/or to maintain headline forex reserves

India's rating upgrade challenge as debt woes trump fiscal prudence: Fitch

In August, Fitch affirmed India's long-term foreign currency issuer rating at 'BBB-' with a stable outlook, citing a strong medium-term growth outlook